Shayna Egan

Director, Endpoint Development And Strategy at Ultragenyx Pharmaceutical

Shayna Egan, MPH, currently serves as Director at Lumanity, having transitioned from a similar role at Endpoint Outcomes, where leadership spanned multiple positions from Senior Project Manager to Director over an eight-year tenure. With extensive experience managing qualitative research studies focused on clinical outcome assessments and novel endpoints for clinical trials, Shayna has been instrumental in coordinating project execution, timeline management, and client communication. Prior roles include Project Coordinator at Boston Medical Center, where leadership in studies targeted health improvements for young African American women and chronic pain management, along with experience in environmental health research in Kenya and developing sustainability programming at Wake Forest University. Shayna holds a Bachelor of Science in Health and Exercise Science from Wake Forest University and a Master of Public Health in International Health from Boston University.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Ultragenyx Pharmaceutical

11 followers

Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.


Industries

Employees

501-1,000

Links